Silencing of the cytokine receptor TNFRSF13B: A new therapeutic target for triple-negative breast cancer

MLA

Mahmoud T. Abo-Elfadl, et al. “Silencing of the Cytokine Receptor TNFRSF13B: A New Therapeutic Target for Triple-Negative Breast Cancer.” Cytokine, vol. 125, May 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d0c963b5cdf6576e621c50192e822348&authtype=sso&custid=ns315887.

APA

Mahmoud T. Abo-Elfadl, Nancy N. Shahin, Amira M. Gamal-Eldeen, & Manal F. Ismail. (2019). Silencing of the cytokine receptor TNFRSF13B: A new therapeutic target for triple-negative breast cancer. Cytokine, 125.

Chicago

Mahmoud T. Abo-Elfadl, Nancy N. Shahin, Amira M. Gamal-Eldeen, and Manal F. Ismail. 2019. “Silencing of the Cytokine Receptor TNFRSF13B: A New Therapeutic Target for Triple-Negative Breast Cancer.” Cytokine 125 (May). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d0c963b5cdf6576e621c50192e822348&authtype=sso&custid=ns315887.